AbbVie
ABBV
ABBV
3,762 hedge funds and large institutions have $264B invested in AbbVie in 2025 Q1 according to their latest regulatory filings, with 262 funds opening new positions, 1,472 increasing their positions, 1,598 reducing their positions, and 124 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
3,762
Holders Change
+64
Holders Change %
+1.73%
% of All Funds
51.09%
Holding in Top 10
243
Holding in Top 10 Change
+77
Holding in Top 10 Change %
+46.39%
% of All Funds
3.3%
New
262
Increased
1,472
Reduced
1,598
Closed
124
Calls
$3.94B
Puts
$3.43B
Net Calls
+$502M
Net Calls Change
+$310M
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$1.16B |
| 2 |
BlackRock
New York
|
+$805M |
| 3 |
JPMorgan Chase & Co
New York
|
+$627M |
| 4 |
Goldman Sachs
New York
|
+$598M |
| 5 |
Barclays
London,
United Kingdom
|
+$572M |
